Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
Dr. Marc Suárez delivers plenary session at AAIC Neuroscience Next 2026
During his presentation, he highlighted biomarker advances, from biology to their application in patients and clinical settings.
BBRC researchers take part in a Nature Aging study validating blood biomarkers in diverse populations
The study strengthens the validity of blood-based biomarkers for detecting Alzheimer’s disease and other dementias in diverse population settings, representing a key step towards more accessible and equitable diagnosis
Study links locus coeruleus status to deep sleep quality in aging and Alzheimer's disease
This research describes new mechanisms linking the locus coeruleus to deep sleep and reveals differences according to sex and cerebral vascular status.
The BBRC consolidates sustained growth in female research talent
In 2025, women represent 68.4% of the BBRC’s workforce and play a prominent role in research and leadership
A standardised protocol reduces post-lumbar puncture headache after cerebrospinal fluid extractions
The study analysed 1147 lumbar punctures performed on 724 participants in the ALFA study
Once again, we are taking part in the #científiques initiative
As part of the International Day of Women and Girls in Science, the BBRC is taking part for the second consecutive year in this initiative, which aims to highlight the strategic role of women in science and technology.
The BBRC leads a project to validate Alzheimer’s biomarkers in diverse communities
The project is one of 13 selected in this year’s edition, which aims to support emerging research projects in the fields of health and sustainability in Barcelona.
Natàlia Soldevila awarded Juan de la Cierva fellowship to advance research on the prevention of cognitive decline
The €76,600 grant will enable Dr Soldevila to develop her research line within the Clinical Research and Risk Factors for Neurodegenerative Diseases Group at the BBRC.
BBRC researchers contribute to landmark Springer Volume on biomarkers of neurodegenerative disorders
The book is leading reference on biomarkers shaping diagnosis, prognosis, and therapy development in Alzheimer’s disease and related dementias.
